 |
The Journal of Neuroscience, June 15, 2005, 25(24):5757-5762; doi:10.1523/JNEUROSCI.4748-04.2005
Previous Article | Next Article 
BRIEF COMMUNICATION
The ErbB4 Neuregulin Receptor Mediates Suppression of Oligodendrocyte Maturation
Caroline R. Sussman,1
Timothy Vartanian,3 and
Robert H. Miller2
Departments of 1Physiology and Biophysics and 2Neurosciences, Case Western Reserve University, Cleveland, Ohio 44106-4965, and 3Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115
Neuregulin is required for proper oligodendrocyte development, but which receptors are involved and whether neuregulin promotes or inhibits maturation remain controversial. To assess the roles of the neuregulin receptor ErbB4 in oligodendrocyte development, we examined oligodendrocyte initiation and maturation in cultures derived from erbB4 knock-out mice and rat spinal cord in the presence of neutralizing erbB4 antibodies. No differences in the development of O4+ oligodendrocytes were detected in the presence or absence of erbB4 signaling. All four epidermal growth factor receptor family members were detected in the ventral neural tube at approximately the time of initial oligodendrocyte development, consistent with redundancy in neuregulin receptor signaling at the onset of oligodendrocyte development. In contrast, greater numbers of differentiated (monoclonal antibody O1+) oligodendrocytes developed in neural tube explants from erbB4-/- mice than either erbB4+/+ or erbB4+/- littermates as well as in cultures treated with anti-erbB4. These data indicate that ErbB4 is not required for oligodendrocyte development and, in fact, inhibits oligodendrocyte lineage maturation. Together with previous studies, these data suggest a model in which early oligodendrocyte lineage development is regulated by promiscuous neuregulin receptor signaling, but subsequent lineage progression occurs through a balance of receptor-specific promotion or inhibition of maturation.
Key words: differentiation; neural tube; oligodendrocyte; receptor; growth factor; embryo; neuregulin; erbB4; spinal cord; CNS; immunohistochemistry; knock-out
Received Nov 19, 2004;
revised May 3, 2005;
accepted May 3, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
N. Hoshina, T. Tezuka, K. Yokoyama, H. Kozuka-Hata, M. Oyama, and T. Yamamoto
Focal adhesion kinase regulates laminin-induced oligodendroglial process outgrowth.
Genes Cells,
November 1, 2007;
12(11):
1245 - 1254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Simons and K. Trajkovic
Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis
J. Cell Sci.,
November 1, 2006;
119(21):
4381 - 4389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Georgieva, V. Moskvina, T. Peirce, N. Norton, N. J. Bray, L. Jones, P. Holmans, S. MacGregor, S. Zammit, J. Wilkinson, et al.
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia
PNAS,
August 15, 2006;
103(33):
12469 - 12474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Carteron, A. Ferrer-Montiel, and H. Cabedo
Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival
J. Cell Sci.,
March 1, 2006;
119(5):
898 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|